Trial Profile
Antihypertensive Effect of Different Doses of ROSTAFUROXIN in Comparison With Losartan, Assessed by Office and Ambulatory Blood Pressure Monitoring in a Hypertensive Population Selected According to a Specific Genetic Profile.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 23 Feb 2023
Price :
$35
*
At a glance
- Drugs Rostafuroxin (Primary) ; Losartan
- Indications Hypertension
- Focus Therapeutic Use
- Sponsors CVie Therapeutics; Windtree Therapeutics
- 17 Feb 2023 Planned End Date changed from 1 Dec 2017 to 8 Feb 2018.
- 17 Feb 2023 Planned primary completion date changed from 1 Dec 2017 to 8 Feb 2018.
- 17 Feb 2023 Status changed from recruiting to completed.